GSA Capital Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$462K Buy
2025
Q2
Sell
2025
Q1
$367K Buy
2022
Q2
Sell
2022
Q1
$371K Buy
2021
Q4
Sell
2021
Q3
$296K Buy
2020
Q1
Sell
2019
Q4
$1.2M Buy
2018
Q2
Sell
2018
Q1
$861K Sell
2017
Q4
$1.89M Buy